BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31855275)

  • 1. Targetoid erythema surrounding multiple seborrheic keratoses induced by chemotherapy with gemcitabine.
    Retrosi C; Vezzoni R; Conforti C; Corneli P; Magaton-Rizzi G; Zalaudek I; Di Meo N
    Acta Dermatovenerol Alp Pannonica Adriat; 2019 Dec; 28(4):185-186. PubMed ID: 31855275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inflammation of multiple seborrheic keratoses induced by chemotherapy with gemcitabine].
    Siqueira CR; Miot HA
    An Bras Dermatol; 2009; 84(4):410-3. PubMed ID: 19851675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma.
    Kuku I; Kaya E; Sevinc A; Aydogdu I
    J Eur Acad Dermatol Venereol; 2002 May; 16(3):271-2. PubMed ID: 12195570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine-induced acute lipodermatosclerosis-like reaction.
    Chu CY; Yang CH; Chiu HC
    Acta Derm Venereol; 2001; 81(6):426-8. PubMed ID: 11859947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time- and dose-limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabine--a report of three cases.
    Brandes A; Reichmann U; Plasswilm L; Bamberg M
    Anticancer Drugs; 2000 Jan; 11(1):15-7. PubMed ID: 10757558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced subacute cutaneous lupus erythematosus--filling the gap in knowledge: comment on "subacute cutaneous lupus erythematosus induced by chemotherapy".
    Callen JP
    JAMA Dermatol; 2013 Sep; 149(9):1075-6. PubMed ID: 23842706
    [No Abstract]   [Full Text] [Related]  

  • 7. Subacute cutaneous lupus erythematosus induced by chemotherapy: gemcitabine as a causative agent.
    Wiznia LE; Subtil A; Choi JN
    JAMA Dermatol; 2013 Sep; 149(9):1071-5. PubMed ID: 23842655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation of seborrheic keratoses caused by cytarabine: a pseudo sign of Leser-Trelat.
    Patton T; Zirwas M; Nieland-Fisher N; Jukic D
    J Drugs Dermatol; 2004; 3(5):565-6. PubMed ID: 15552612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine-associated CD8+ CD30+ pseudolymphoma.
    Marucci G; Sgarbanti E; Maestri A; Calandri C; Collina G
    Br J Dermatol; 2001 Oct; 145(4):650-2. PubMed ID: 11703296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent cutaneous toxic erythema induced by gemcitabine in a patient with pancreatic cancer.
    Li J; Ko CJ; Saif MW
    Cutan Ocul Toxicol; 2009; 28(3):144-8. PubMed ID: 19527102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Livedo racemosa and hemolytic uremic syndrome induced by gemcitabine.
    Tognetti L; Garosi G; Rongioletti F; Fimiani M; Rubegni P
    Int J Dermatol; 2016 Oct; 55(10):e555-6. PubMed ID: 27125732
    [No Abstract]   [Full Text] [Related]  

  • 12. Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment.
    Peramiquel L; Dalmau J; Puig L; Roé E; Fernández-Figueras MT; Alomar A
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S119-20. PubMed ID: 17052530
    [No Abstract]   [Full Text] [Related]  

  • 13. Bullous dermatosis associated with gemcitabine therapy for non-small-cell lung carcinoma.
    Imen A; Amal K; Ines Z; Sameh el F; Fethi el M; Habib G
    Respir Med; 2006 Aug; 100(8):1463-5. PubMed ID: 16434173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent lower extremity pseudocellulitis.
    Korniyenko A; Lozada J; Ranade A; Sandhu G
    Am J Ther; 2012 Jul; 19(4):e141-2. PubMed ID: 22772033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eruptive seborrheic keratoses secondary to telaprevir-related dermatitis.
    Chadwick PW; Heymann WR
    Cutis; 2016 Aug; 98(2):E20-1. PubMed ID: 27622264
    [No Abstract]   [Full Text] [Related]  

  • 16. A rash diagnosis: Gemcitabine-associated pseudocellulitis.
    Strouse C; Epperla N
    J Oncol Pharm Pract; 2017 Mar; 23(2):157-160. PubMed ID: 26946530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient eruptive seborrheic keratoses associated with erythrodermic psoriasis and erythrodermic drug eruption: report of two cases.
    Flugman SL; McClain SA; Clark RA
    J Am Acad Dermatol; 2001 Dec; 45(6 Suppl):S212-4. PubMed ID: 11712062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-induced inflammation in seborrheic keratoses mimicking disseminated herpes zoster.
    Williams JV; Helm KF; Long D
    J Am Acad Dermatol; 1999 Apr; 40(4):643-4. PubMed ID: 10188692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side effects of chemotherapy. Case 3. Acute interstitial pneumonitis related to gemcitabine.
    Attar EC; Ervin T; Janicek M; Deykin A; Godleski J
    J Clin Oncol; 2000 Feb; 18(3):697-8. PubMed ID: 10653887
    [No Abstract]   [Full Text] [Related]  

  • 20. An unusual case of gemcitabine-induced radiation recall.
    Squire S; Chan M; Feller E; Mega A; Gold R
    Am J Clin Oncol; 2006 Dec; 29(6):636. PubMed ID: 17149004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.